ProPhase Labs, Inc. (PRPH)
NASDAQ: PRPH · Real-Time Price · USD
1.450
-0.490 (-25.26%)
Nov 7, 2024, 3:31 PM EST - Market open

ProPhase Labs Market Cap

ProPhase Labs has a market cap or net worth of $27.66 million as of November 7, 2024. Its market cap has decreased by -63.41% in one year.

Market Cap
27.66M
Enterprise Value
62.05M
1-Year Change
-63.41%
Ranking
Category
Stock Price
$1.45

Market Cap Chart

Since December 1, 1998, ProPhase Labs's market cap has decreased from $92.00M to $27.66M, a decrease of -69.93%. That is a compound annual growth rate of -4.52%.

History

DateMarket Cap% Change
Nov 6, 202437.00M-54.66%
Dec 29, 202381.60M-47.96%
Dec 30, 2022156.80M41.01%
Dec 31, 2021111.20M4.41%
Dec 31, 2020106.50M367.11%
Dec 31, 201922.80M-37.36%
Dec 31, 201836.40M34.81%
Dec 29, 201727.00M-21.05%
Dec 30, 201634.20M33.59%
Dec 31, 201525.60M13.27%
Dec 31, 201422.60M-11.72%
Dec 31, 201325.60M26.73%
Dec 31, 201220.20M19.53%
Dec 30, 201116.90M-3.98%
Dec 31, 201017.60M-30.98%
Dec 31, 200925.50M-50.58%
Dec 31, 200851.60M-15.69%
Dec 31, 200761.20M-15.24%
Dec 29, 200672.20M-55.24%
Dec 30, 2005161.30M64.42%
Dec 31, 200498.10M-19.85%
Dec 31, 2003122.40M94.29%
Dec 31, 200263.00M156.10%
Dec 31, 200124.60M179.55%
Dec 29, 20008.80M-46.67%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Lumos Pharma 35.46M
Beyond Air 35.37M
Outset Medical 35.26M
Neuronetics 34.54M
Curis 34.50M
Daré Bioscience 33.76M
Burning Rock Biotech 33.75M
AEON Biopharma 33.59M
Market Cap Rankings